Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.
Cardlytics, Inc. (CDLX) had Cost of Goods Sold of $36.74M for the most recently reported fiscal quarter, ending 2025-03-31.
Income Statement Financials | |
$61.90M |
|
$-13.28M |
|
Cost of Goods Sold |
$36.74M |
$25.16M |
|
$75.98M |
|
$-14.08M |
|
$0.80M |
|
$-13.28M |
|
$-13.28M |
|
$-13.28M |
|
$-13.28M |
|
$-13.28M |
|
$-13.28M |
|
$-14.08M |
|
$-6.75M |
|
51.86M |
|
51.86M |
|
$-0.26 |
|
$-0.26 |
|
Balance Sheet Financials | |
$156.83M |
|
$2.47M |
|
$212.24M |
|
$369.07M |
|
$131.85M |
|
$168.01M |
|
$173.13M |
|
$304.98M |
|
$64.09M |
|
$-105.25M |
|
$64.09M |
|
52.17M |
|
Cash Flow Statement Financials | |
$-6.71M |
|
$-3.90M |
|
$-3.03M |
|
$65.59M |
|
$52.05M |
|
$-13.55M |
|
$8.69M |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
1.19 |
|
-- |
|
-- |
|
0.72 |
|
3.34 |
|
40.65% |
|
-22.75% |
|
-22.75% |
|
-- |
|
-21.46% |
|
-21.46% |
|
$-10.81M |
|
-- |
|
-- |
|
-- |
|
0.17 |
|
-- |
|
0.62 |
|
144.60 |
|
-20.72% |
|
12.62% |
|
-3.60% |
|
-5.72% |
|
$1.23 |
|
$-0.21 |
|
$-0.13 |